news

Self-regulating nanoparticles could treat cancer

Scientists have developed ‘intelligent’ nanoparticles which heat up to a temperature high enough to kill cancerous cells…

nanoparticles

Scientists have developed ‘intelligent’ nanoparticles which heat up to a temperature high enough to kill cancerous cells – but which then self-regulate and lose heat before they get hot enough to harm healthy tissue.

The self-stopping nanoparticles could soon be used as part of hyperthermic-thermotherapy to treat patients with cancer.

If we can keep cancer treatment sat at a temperature level high enough to kill cancer, while low enough to stop harming healthy tissue, it will prevent some of the serious side effects of vital treatment

Thermotherapy has long been used as a treatment method for cancer, but it is difficult to treat patients without damaging healthy cells. However, tumour cells can be weakened or killed without affecting normal tissue if temperatures can be controlled accurately within a range of 42°C to 45°C.

 

Access your FREE copy

 


Biomarkers aren’t just supporting drug discovery – they’re driving it

FREE market report

From smarter trials to faster insights, this report unpacks the science, strategy and real-world impact behind the next generation of precision therapies.

What you’ll unlock:

  • How biomarkers are guiding dose selection and early efficacy decisions in complex trials
  • Why multi-omics, liquid biopsy and digital tools are redefining the discovery process
  • What makes lab data regulatory-ready and why alignment matters from day one

Explore how biomarkers are shaping early drug development

Access the full report – it’s free!

 

Scientists from the University of Surrey’s Advanced Technology Institute have worked with colleagues from the Dalian University of Technology in China to create nanoparticles which, when implanted and used in a thermotherapy session, can induce temperatures of up to 45°C.

The Zn-Co-Cr ferrite nanoparticles produced for this study are self-regulating, meaning that they self-stop heating when they reach temperatures over 45°C. Importantly, the nanoparticles are also low in toxicity and are unlikely to cause permanent damage to the body.

Professor Ravi Silva, Head of the Advanced Technology Institute at the University of Surrey, said: “This could potentially be a game changer in the way we treat people who have cancer. If we can keep cancer treatment sat at a temperature level high enough to kill cancer, while low enough to stop harming healthy tissue, it will prevent some of the serious side effects of vital treatment.

“It’s a very exciting development which, once again, shows that the University of Surrey research is at the forefront of nanotechnologies – whether in the field of energy materials or, in this case, healthcare.”

Dr Wei Zhang, Associate Professor from Dalian University of Technology said: “Magnetic induced hyperthermia is a traditional route of treating malignant tumours. However, the difficulties in temperature control have significantly restricted its usage If we can modulate the magnetic properties of the nanoparticles, the therapeutic temperature can be self-regulated, eliminating the use of clumsy temperature monitoring and controlling systems.

“By making magnetic materials with the Curie temperature falling in the range of hyperthermia temperatures, the self-regulation of therapeutics can be achieved. For the most magnetic materials, however, the Curie temperature is much higher than the human body can endure. By adjusting the components as we have, we have synthesised the nanoparticles with the Curie temperature as low as 34oC. This is a major nanomaterials breakthrough.”

Leave a Reply

Your email address will not be published. Required fields are marked *